Biocon Ltd

  • BSE Code : 532523
  • NSE Symbol : BIOCON
  • ISIN : INE376G01013
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 359.65 -2.60(-0.72%)

Open Price ()

360.50

Prev. Close ()

362.25

Volume (No’s)

1,996,623

Market Cap ()

58,295.95

Low Price ()

354.25

High Price ()

361.65

 

Board Meetings

Start Date End Date Purpose
23-Apr-2026 07-May-2026 Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2026 inter alia to consider and approve Intimation of the Board Meeting and Earnings Conference Call for Analysts and Investors
27-Mar-2026 27-Mar-2026 Outcome Of Board Meeting
13-Jan-2026 12-Feb-2026 Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve Intimation for the Board Meeting and Earnings Conference Call for Analysts and Investors Outcome of Board Meeting- In-principle approval of Acquisition. Outcome of Board Meeting (As Per BSE Announcement Dated on 12.02.2026)
03-Dec-2025 06-Dec-2025 Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/12/2025 ,inter alia, to consider and approve Intimation of Board Meeting Outcome of Board Meeting under Regulation 30 of SEBI Listing Regulations, 2015 (As per BSE Announcement dated on: 06.12.2025)
06-Oct-2025 11-Nov-2025 Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve Intimation of the date of Board Meeting Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve Update on prior intimation of Board Meeting to be held for consideration and approval of early redemption of NCDs and raising of funds through issuance of Commercial Papers (As Per BSE Announcement Dated on: 06/11/2025) Financial results for Quarter and Half year ended 30 September, 2025 Outcome of Board meeting held on November 11, 2025 Outcome of Board Meeting _ Early full redemption of Non-Convertible Debentures Outcome of Board Meeting _ Acquisition of Compulsory Convertible Debentures. Outcome of Board meeting _ Raising of funds through issuance of commercial papers (As Per BSE Announcement Dated on 11.11.2025)

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew